The malaria treatment market was valued at US$ 1,508.12 million in 2019 and is projected to reach US$ 2,126.42 million by 2027; it is expected to grow at a CAGR of 4.4% from 2020 to 2027.
Malaria is a life-threatening infectious disease caused by the Plasmodium parasite. The high prevalence of malaria in low-income countries and increasing initiatives undertaken by governments globally are driving the malaria treatment market, and is also expected to foster the market growth during the forecast period. However, increasing resistance to antimalarial drugs is restricting the market growth.
To request a sample copy or view summary of this report, click the link below@ https://www.theinsightpartners.com/sample/TIPRE00018229/
In the early phase of the pandemic owing to the urgency for efficient COVID-19 treatment therapeutics, in April 2020, the European Medicines Agency started investigation of Chloroquine and hydroxychloroquine (antimalarial drugs) for their potential to treat COVID-19. This has led to the increase in demand of antimalarial drugs in the management of COVID-19.
High Prevalence of Malaria in Low-Income Countries Drives Malaria Treatment Market Growth
Malaria is a life-threatening infectious disease caused by the Plasmodium parasite and spread by female Anopheles mosquitoes. The malaria epidemic is on the rise, and climate change is further creating an environment for vector mosquitoes to thrive. As per the WHO, around 229 million malaria cases and ~409,000 deaths were recorded globally in 2019. Malaria has predominantly affected tropical regions, including Africa and Asia, Central and South America. Also, most cases of malaria occur in Africa, South-East Asia, the Eastern Mediterranean, and Western Pacific.
Global Manufacturers of Malaria Treatment Market Report Are:
Ipca Laboratories Ltd
Sun Pharmaceutical Industries Ltd
TEVA PHARMACEUTICAL INDUSTRIES LTD
As per the WHO, African region accounts for the highest share of the global malaria burden. As per the WHO, in 2019, the region accounted for around 94% of malaria cases and deaths. Also, six countries in the region accounted for half of all malaria deaths worldwide: Nigeria (23%), the Democratic Republic of the Congo (11%), United Republic of Tanzania (5%), Burkina Faso (4%), Mozambique (4%) and Niger (4%). Children and pregnant women are the most vulnerable group affected by malaria. In 2019, children accounted for 67% (274,000) of all malaria deaths worldwide.
Malaria Treatment Market – by Treatment Type
Malaria Treatment Market – by End User
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00018229/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.